Pharmaceutical Biocatalysis : Drugs, Genetic Diseases, and Epigenetics / edited by Peter Grunwald.
| Call Number | 660.6/34 |
| Title | Pharmaceutical Biocatalysis : Drugs, Genetic Diseases, and Epigenetics / edited by Peter Grunwald. |
| Physical Description | 1 online resource : illustrations (some color) |
| Series | Jenny Stanford Series on Biocatalysis ; volume 7 |
| Contents | Cover -- Half Title -- Title Page -- Copyright Page -- Table of Contents -- Preface -- Chapter 1: Fermentative Production of Vitamin B6 -- 1.1: Introduction -- 1.2: De novo Synthesis of Vitamin B6 -- 1.3: Control of Vitamin B6 Homeostasis -- 1.4: Engineering Microorganisms for the Production of B6 Vitamers -- 1.5: Novel Routes for Vitamin B6 Biosynthesis and Production -- 1.6: Rational Design and Construction of a Vitamin B6-Producing Bacterium -- 1.7: Alternative Approaches for Enhancing Vitamin B6 Production -- 1.8: Conclusions Chapter 4: Microbial Biotransformations in the Production and Degradation of Fluorinated Pharmaceuticals -- 4.1: Introduction -- 4.2: Fluorinated Natural Products -- 4.3: Production of Fluorinated Antibiotics in Microorganisms -- 4.4: Biological Production of [18F]-Labelled Compounds for PET Analysis -- 4.5: Microorganisms that Enable Fluorinated Drug Design -- 4.6: Production of Fluorinated Drug Metabolites in Microorganisms -- 4.7: Microbial Degradation of Fluorinated Drugs -- 4.8: Future Prospects and Challenges |
| Summary | Volume 7 of the Jenny Stanford Series on Biocatalysis deals with several different aspects of pharmaceuticals, which include not only various applications of drugs and their metabolism but also natural resources for active pharmaceutical ingredients as well as the removal of pharmaceutical pollution. In detail, novel approaches for developing microbial fermentation processes to produce vitamin B6 using microorganisms are described together with novel routes for vitamin B6 biosynthesis. The other topics discussed are new approaches for producing the successful anticancer drug Taxol from naturally occurring precursors, molecular farming through plant engineering as a cost-effective means to produce therapeutic and prophylactic proteins, and successful screening of potent microorganisms producing L-asparaginase for various chemotherapeutic applications. Furthermore, microbial biotransformations in the production and degradation of fluorinated pharmaceuticals are described. The other chapters inform the reader about the biotransformation of xenobiotics/drugs in living systems, the degradation of pharmaceuticals by white-rot fungi and their ligninolytic enzymes, and the removal of pharmaceutical pollution from municipal sewage using laccase. |
| Added Author | Grunwald, Peter, 1941- editor. |
| Subject | Enzymes Industrial applications. BIOCATALYSIS. PHARMACEUTICAL CHEMISTRY. MEDICAL / Pharmacy SCIENCE / Biotechnology SCIENCE / Chemistry / General |
| Multimedia |
Total Ratings:
0
04501cam a2200613Ii 4500
001
vtls001592517
003
VRT
005
20220808223100.0
006
m o d
007
cr |||||||||||
008
220808s2021 si a go 000 0 eng d
020
$a 9781003045410 $q electronic book
020
$a 1003045413 $q electronic book
020
$a 9781000067385 $q electronic book
020
$a 1000067386 $q electronic book
020
$a 9781000067408 $q (EPUB)
020
$a 1000067408 $q (EPUB)
020
$a 9781000067392 $q (electronic bk. : Mobipocket)
020
$a 1000067394 $q (electronic bk. : Mobipocket)
020
$z 981487714X
020
$z 9789814877145
024
7
$a 10.1201/9781003045410 $2 doi
035
$a (OCoLC)1196195768
035
$a (OCoLC-P)1196195768
035
$a (FlBoTFG)9781003045410
039
9
$a 202208082231 $b santha $y 202206301325 $z santha
040
$a OCoLC-P $b eng $e rda $c OCoLC-P
050
4
$a TP248.65.E59 $b P43 2021
072
7
$a MED $x 072000 $2 bisacsh
072
7
$a SCI $x 010000 $2 bisacsh
072
7
$a SCI $x 013000 $2 bisacsh
072
7
$a MQP $2 bicssc
082
0
4
$a 660.6/34 $2 23
245
0
0
$a Pharmaceutical Biocatalysis : $b Drugs, Genetic Diseases, and Epigenetics / $c edited by Peter Grunwald.
264
1
$a Singapore : $b Jenny Stanford Publishing, $c [2021]
300
$a 1 online resource : $b illustrations (some color)
336
$a text $2 rdacontent
337
$a computer $2 rdamedia
338
$a online resource $2 rdacarrier
490
1
$a Jenny Stanford Series on Biocatalysis ; $v volume 7
505
0
$a Cover -- Half Title -- Title Page -- Copyright Page -- Table of Contents -- Preface -- Chapter 1: Fermentative Production of Vitamin B6 -- 1.1: Introduction -- 1.2: De novo Synthesis of Vitamin B6 -- 1.3: Control of Vitamin B6 Homeostasis -- 1.4: Engineering Microorganisms for the Production of B6 Vitamers -- 1.5: Novel Routes for Vitamin B6 Biosynthesis and Production -- 1.6: Rational Design and Construction of a Vitamin B6-Producing Bacterium -- 1.7: Alternative Approaches for Enhancing Vitamin B6 Production -- 1.8: Conclusions
505
8
$a Chapter 4: Microbial Biotransformations in the Production and Degradation of Fluorinated Pharmaceuticals -- 4.1: Introduction -- 4.2: Fluorinated Natural Products -- 4.3: Production of Fluorinated Antibiotics in Microorganisms -- 4.4: Biological Production of [18F]-Labelled Compounds for PET Analysis -- 4.5: Microorganisms that Enable Fluorinated Drug Design -- 4.6: Production of Fluorinated Drug Metabolites in Microorganisms -- 4.7: Microbial Degradation of Fluorinated Drugs -- 4.8: Future Prospects and Challenges
520
$a Volume 7 of the Jenny Stanford Series on Biocatalysis deals with several different aspects of pharmaceuticals, which include not only various applications of drugs and their metabolism but also natural resources for active pharmaceutical ingredients as well as the removal of pharmaceutical pollution. In detail, novel approaches for developing microbial fermentation processes to produce vitamin B6 using microorganisms are described together with novel routes for vitamin B6 biosynthesis. The other topics discussed are new approaches for producing the successful anticancer drug Taxol from naturally occurring precursors, molecular farming through plant engineering as a cost-effective means to produce therapeutic and prophylactic proteins, and successful screening of potent microorganisms producing L-asparaginase for various chemotherapeutic applications. Furthermore, microbial biotransformations in the production and degradation of fluorinated pharmaceuticals are described. The other chapters inform the reader about the biotransformation of xenobiotics/drugs in living systems, the degradation of pharmaceuticals by white-rot fungi and their ligninolytic enzymes, and the removal of pharmaceutical pollution from municipal sewage using laccase.
588
$a OCLC-licensed vendor bibliographic record.
650
0
$a Enzymes $x Industrial applications.
650
0
$a BIOCATALYSIS.
650
0
$a PHARMACEUTICAL CHEMISTRY.
650
7
$a MEDICAL / Pharmacy $2 bisacsh
650
7
$a SCIENCE / Biotechnology $2 bisacsh
650
7
$a SCIENCE / Chemistry / General $2 bisacsh
700
1
$a Grunwald, Peter, $d 1941- $e editor.
856
4
0
$3 Taylor & Francis $u https://www.taylorfrancis.com/books/9781003045410
856
4
2
$3 OCLC metadata license agreement $u http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf
999
$a VIRTUA
No Reviews to Display
| Summary | Volume 7 of the Jenny Stanford Series on Biocatalysis deals with several different aspects of pharmaceuticals, which include not only various applications of drugs and their metabolism but also natural resources for active pharmaceutical ingredients as well as the removal of pharmaceutical pollution. In detail, novel approaches for developing microbial fermentation processes to produce vitamin B6 using microorganisms are described together with novel routes for vitamin B6 biosynthesis. The other topics discussed are new approaches for producing the successful anticancer drug Taxol from naturally occurring precursors, molecular farming through plant engineering as a cost-effective means to produce therapeutic and prophylactic proteins, and successful screening of potent microorganisms producing L-asparaginase for various chemotherapeutic applications. Furthermore, microbial biotransformations in the production and degradation of fluorinated pharmaceuticals are described. The other chapters inform the reader about the biotransformation of xenobiotics/drugs in living systems, the degradation of pharmaceuticals by white-rot fungi and their ligninolytic enzymes, and the removal of pharmaceutical pollution from municipal sewage using laccase. |
| Contents | Cover -- Half Title -- Title Page -- Copyright Page -- Table of Contents -- Preface -- Chapter 1: Fermentative Production of Vitamin B6 -- 1.1: Introduction -- 1.2: De novo Synthesis of Vitamin B6 -- 1.3: Control of Vitamin B6 Homeostasis -- 1.4: Engineering Microorganisms for the Production of B6 Vitamers -- 1.5: Novel Routes for Vitamin B6 Biosynthesis and Production -- 1.6: Rational Design and Construction of a Vitamin B6-Producing Bacterium -- 1.7: Alternative Approaches for Enhancing Vitamin B6 Production -- 1.8: Conclusions Chapter 4: Microbial Biotransformations in the Production and Degradation of Fluorinated Pharmaceuticals -- 4.1: Introduction -- 4.2: Fluorinated Natural Products -- 4.3: Production of Fluorinated Antibiotics in Microorganisms -- 4.4: Biological Production of [18F]-Labelled Compounds for PET Analysis -- 4.5: Microorganisms that Enable Fluorinated Drug Design -- 4.6: Production of Fluorinated Drug Metabolites in Microorganisms -- 4.7: Microbial Degradation of Fluorinated Drugs -- 4.8: Future Prospects and Challenges |
| Subject | Enzymes Industrial applications. BIOCATALYSIS. PHARMACEUTICAL CHEMISTRY. MEDICAL / Pharmacy SCIENCE / Biotechnology SCIENCE / Chemistry / General |
| Multimedia |